RBI Bonus Zert 1FC 26.03.2025/ AT0000A37M38 /
| 5/13/2024 9:16:15 AM | Chg.+0.12 | Bid9:29:28 AM | Ask9:29:28 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 6.51EUR | +1.88% | 6.53 Bid Size: 2,000 |
6.55 Ask Size: 2,000 |
FACC AG INH.AKT. | - EUR | 3/26/2025 | Call |
GlobeNewswire
5/7
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire
5/7
Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina
GlobeNewswire
5/2
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire
4/30
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire
4/8
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire
4/7
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire
4/1
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire
3/27
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire
3/25
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire
3/25
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire
3/13
Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire
3/12
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire
2/27
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire
2/20
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire
2/7
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire
1/29
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...
GlobeNewswire
1/23
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
GlobeNewswire
12/27/2023
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammato...
GlobeNewswire
12/20/2023
Renexxion Ireland has Completed a Successful Pre-IND Consultation with the United States FDA for Dev...
